1. Antacid vs placebo in hospitalized gastric ulcer patients: a controlled therapeutic study;Butler, M.L.; Gersh, H.;American Journal of Digestive Diseases,1975
2. Verlauf der peptischen Ulkuskrankheit im endoskopischen Bild bei 125 Fallen;Gaisberg, Von; U., Heinkel; K., Kimmig; M., J.; Kleen, U.; Spanknebel, H.;Zeitschrift far Gastroenterologie,1975
3. Wartogd diagnostyczna fiberoduodenoskopii;Gibifiski, K.; Nowak, A.; Rybicka, J.; Zmudziiiska, M.; Toborek, N.;Przeglad Lekarski,1974
4. The effect of 16, 16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients;Ippoliti, A.F.; Isenberg, J.I.; Maxwell, V.; Walsh, J.H.;Gastroenterology,1976
5. Effect of orally administered prostaglandin E2 and its 15-methyl analogues on gastric secretion;Karim, S.M.; Carter, D.C.; Bhana, D.; Ganesan, P.A.;British Medical Journal,1973